General MedicationsINJECTIONStandard
VYLOY
ZOLBETUXIMAB-CLZB
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VYLOY is listed in Drugs@FDA under application 761365 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ZOLBETUXIMAB-CLZB Form and strength INJECTABLE;INJECTION - 100MG Sponsor ASTELLAS Submission history Latest submission status date: 2025-06-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview VYLOY is listed in Drugs@FDA under application 761365 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ZOLBETUXIMAB-CLZB Form and strength INJECTABLE;INJECTION - 100MG Sponsor ASTELLAS Submission history Latest submission status date: 2025-06-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.